Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Phenomenex to Host AACC Workshop on LC/MS/MS for Clinical Diagnostics

Published: Friday, May 10, 2013
Last Updated: Friday, May 10, 2013
Bookmark and Share
Two-day, hands-on program to be held May 15 and 16.

Phenomenex Inc. has announced that the company is collaborating with the Southern California Section of the American Association of Clinical Chemistry (AACC) in the development and presentation of a hands-on workshop on liquid chromatography with tandem mass spectrometry (LC/MS/MS).

The two-day training, which will count for 16 continuing education units, will teach clinical lab scientists how to develop and validate LC/MS/MS assays for diagnostic use.

A ratio of one instrument for every four users will ensure hands-on learning. LC/MS/MS is gaining rapid acceptance in the clinical lab due to its specificity and the amount of information it delivers, but the technique requires special training and skills.

The workshop, “Hands-On Development and Validation of LC/MS/MS Assays for Clinical Diagnostics,” was originally conceived by Dr. Paul Fu Sr. of the Harbor-UCLA Medical Center, longstanding education chair of the AACC’s Southern California Section.

“LC/MS/MS is a valuable tool in the clinical and healthcare settings,” commented Fu. “Phenomenex is the ideal partner to help us provide hands-on training in this technique because of their expertise in HPLC and their close relationship with AB SCIEX, a leading provider of mass spectrometry.”

Workshop instructors will be Seyed Sadjadi, clinical LC/MS/MS group leader at Phenomenex, who has prior experience at Quest Diagnostics and several mass spectrometry companies; Jenny Moshin, senior field application specialist for AB SCIEX; Brett Holmquist, Ph.D., associate director of the Labcorp’s Endocrine Sciences Laboratory (Esoterix Division); and David Truong, scientist within the PhenoLogix applications group at Phenomenex.

The workshop is partially underwritten by the Southern California Section of AACC, reducing the registration fee to $249 for members.

“Supporting educational activities for our members is very important to us and we want to make sure that the cost of the course is not a barrier for anyone that wants to attend,” says Eswari Gudipati, chair of the Southern California AACC Section.

The workshop will be held at Phenomenex headquarters in Torrance, CA. Participants may register online at: www.regonline.com/AACCmay.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Autism and Cancer Share a Remarkable Number of Risk Genes
Researchers with the UC Davis Comprehensive Cancer Center, MIND Institute identify more than 40 common genes.
Number Of Known Genetic Risk Factors For Endometrial Cancer Doubled
An international collaboration of researchers has identified five new gene regions that increase a woman’s risk of developing endometrial cancer, one of the most common cancers to affect women, taking the number of known gene regions associated with the disease to nine.
Five New Breast Cancer Genes Found
Discovery of mutations paves the way for personalised treatment of breast cancer.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Magnetic Nanoparticles May Reveal Early Traces Of Cancer
Rice University students’ computer program aids MD Anderson diagnostic initiative .
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
World-First Blood Test For Parkinson's
La Trobe University researchers have developed a world-first diagnostic blood test which could change the lives of people with Parkinson's disease.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!